Related Experiment Video
Updated: Jun 24, 2026

The Antihypertensive Effects and Mechanisms of Huotan Jiedu Tongluo Decoction in Rats with H-Type Hypertension
Published on: May 17, 2024
[Differential hypertensive therapy according to the guidelines].
1Universitätsklinikum Münster, Potstiege 42, Münster, Germany. rahn@uni-muenster.de
Lowering blood pressure through lifestyle changes and medications is key to reducing cardiovascular risk. Most patients need multiple antihypertensive drugs to achieve target blood pressure goals.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Hypertension management requires a multifaceted approach combining lifestyle modifications and pharmacotherapy.
- Achieving target blood pressure is crucial for mitigating cardiovascular risk in hypertensive individuals.
Purpose:
- To outline the principles of antihypertensive therapy, including target blood pressure goals and available drug classes.
- To emphasize the necessity of drug treatment, often in combination, for effective blood pressure control.
Summary:
- Antihypertensive therapy aims to reduce blood pressure and cardiovascular risk using lifestyle changes and medications.
- Target blood pressure is <140/90 mmHg for all hypertensive patients, and <130/80 mmHg for high-risk groups (e.g., diabetes, chronic kidney disease).
- First-choice drug classes include diuretics, beta-blockers, calcium antagonists, ACE-inhibitors, and ARBs, with selection based on side effects and comorbidities. Most patients require combination therapy.
Impact:
- Effective blood pressure control significantly lowers cardiovascular risk.
- Understanding drug selection criteria and the need for combination therapy optimizes patient outcomes.
- This guidance supports clinicians in managing hypertension and preventing associated complications.
Related Concept Videos
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension I: Introduction
Hypertension V: Nursing Management
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension and Regulation of Blood Pressure